BREAKING
Protagonist Therapeutics Jumps 7.0% in Broad Rally 37 minutes ago Valaris Limited Drops 6.7% in Broad Selloff 2 hours ago Talos Energy Inc. Drops 6.2% Amid Sector-Wide Selling 2 hours ago Northern Oil and Gas, Inc. Drops 5.2% in Broad Selloff 2 hours ago Bank7 Corp. Tops Q1 Forecasts With $1.25 EPS, 20.2% Above Consensus 3 hours ago JetBlue Airways Corporation Surges 15.1% in Broad Rally 3 hours ago Celanese Corporation Shares Dropping 5.5% 3 hours ago Akamai Technologies, Inc. Shares Dropping 5.3% 3 hours ago Amazon.com, Inc. (AMZN) Jumps 5.2% to $232.68 3 hours ago Boot Barn Holdings, Inc. Shares Jumping 5.2% 3 hours ago Protagonist Therapeutics Jumps 7.0% in Broad Rally 37 minutes ago Valaris Limited Drops 6.7% in Broad Selloff 2 hours ago Talos Energy Inc. Drops 6.2% Amid Sector-Wide Selling 2 hours ago Northern Oil and Gas, Inc. Drops 5.2% in Broad Selloff 2 hours ago Bank7 Corp. Tops Q1 Forecasts With $1.25 EPS, 20.2% Above Consensus 3 hours ago JetBlue Airways Corporation Surges 15.1% in Broad Rally 3 hours ago Celanese Corporation Shares Dropping 5.5% 3 hours ago Akamai Technologies, Inc. Shares Dropping 5.3% 3 hours ago Amazon.com, Inc. (AMZN) Jumps 5.2% to $232.68 3 hours ago Boot Barn Holdings, Inc. Shares Jumping 5.2% 3 hours ago
ADVERTISEMENT
GALT

All GALT Content

1 articles, transcripts, and reports

USB
Analysis

Galectin Therapeutics 2025 Financial Update

Company Overview  Galectin Therapeutics develops therapies targeting galectin proteins, focusing on its lead drug, belapectin, for MASH cirrhosis. Key Financial...

1 min read